Kane Biotech Inc.: federal grants and contributions: 16 agreements; $8.4M value; 3 departments; 5 programs.
Assay record ASY-CA-1FSVGCM12N · Cite as: Assay Systems, “Kane Biotech Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/kane-biotech-inc/
Commercialize a wound gel treatment
Commercialize a wound gel treatment
Kane Biotech Inc. is undertaking a strategy to build commercial supply chain and quality control capabilities for proprietary products. The alignment of processes and technical expertise in a growing biotechnology company requires key technical skills and company resources to be developed.
The project will focus on the development of pet products that contain Kane Biotech Inc. anti-biofilm technology for the use in the treatment of pet health care conditions.
The Design and Development of products based on the revyve Antimicrobial Wound Gel. The sterile wound gel, primarily intended to be used in surgical rooms for post surgery infection prevention; the spray wound gel, primarily intended to be used for large surface burn wounds to clear any existing infection and protect from subsequent infection. Application and removal wound be contactless for these sensitive wounds; and the wound cleanser that is intended to be used prior to debridement and treatment with the revyve wound gel as part of a wound management regimen. The project involves all st
As part of Multinational Corporate Collaboration Program, the project “DispersinB Wound Gel Development and Commercialization” will focus on scaling up the manufacturing process for DispersinB Wound Gel and ensuring the product meets specifications. The DispersinB Wound Gel is a combination product (device, drug, biologic) that is first of its kind in wound care as it disperses biofilms enzymatically.
To develop a cost-effective fermentation and purification manufacturing process for DispersinB®
Consumer test of Kane's human anti-biofilm shampoo in the West and Northeast submarkets of the US and expansion of Kane's animal health business to international markets with a high or growing demand for animal healthcare products.
To strategically expand bluestem, StrixNB and Vetradent product sales to select international markets with a high and/or growing demand for companion pet oral health care products.
The project will support development of intellectual property capacity within the firm.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.